219 related articles for article (PubMed ID: 23620430)
1. Transduction of photoreceptors with equine infectious anemia virus lentiviral vectors: safety and biodistribution of StarGen for Stargardt disease.
Binley K; Widdowson P; Loader J; Kelleher M; Iqball S; Ferrige G; de Belin J; Carlucci M; Angell-Manning D; Hurst F; Ellis S; Miskin J; Fernandes A; Wong P; Allikmets R; Bergstrom C; Aaberg T; Yan J; Kong J; Gouras P; Prefontaine A; Vezina M; Bussieres M; Naylor S; Mitrophanous KA
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4061-71. PubMed ID: 23620430
[TBL] [Abstract][Full Text] [Related]
2. Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy.
Kong J; Kim SR; Binley K; Pata I; Doi K; Mannik J; Zernant-Rajang J; Kan O; Iqball S; Naylor S; Sparrow JR; Gouras P; Allikmets R
Gene Ther; 2008 Oct; 15(19):1311-20. PubMed ID: 18463687
[TBL] [Abstract][Full Text] [Related]
3. Safety and biodistribution of an equine infectious anemia virus-based gene therapy, RetinoStat(®), for age-related macular degeneration.
Binley K; Widdowson PS; Kelleher M; de Belin J; Loader J; Ferrige G; Carlucci M; Esapa M; Chipchase D; Angell-Manning D; Ellis S; Mitrophanous K; Miskin J; Bantseev V; Nork TM; Miller P; Naylor S
Hum Gene Ther; 2012 Sep; 23(9):980-91. PubMed ID: 22716662
[TBL] [Abstract][Full Text] [Related]
4. Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5.
Parker MA; Erker LR; Audo I; Choi D; Mohand-Said S; Sestakauskas K; Benoit P; Appelqvist T; Krahmer M; Ségaut-Prévost C; Lujan BJ; Faridi A; Chegarnov EN; Steinkamp PN; Ku C; da Palma MM; Barale PO; Ayelo-Scheer S; Lauer A; Stout T; Wilson DJ; Weleber RG; Pennesi ME; Sahel JA; Yang P
Am J Ophthalmol; 2022 Aug; 240():285-301. PubMed ID: 35248547
[TBL] [Abstract][Full Text] [Related]
5. Photoreceptor Progenitor mRNA Analysis Reveals Exon Skipping Resulting from the ABCA4 c.5461-10T→C Mutation in Stargardt Disease.
Sangermano R; Bax NM; Bauwens M; van den Born LI; De Baere E; Garanto A; Collin RW; Goercharn-Ramlal AS; den Engelsman-van Dijk AH; Rohrschneider K; Hoyng CB; Cremers FP; Albert S
Ophthalmology; 2016 Jun; 123(6):1375-85. PubMed ID: 26976702
[TBL] [Abstract][Full Text] [Related]
6. EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat.
Zallocchi M; Binley K; Lad Y; Ellis S; Widdowson P; Iqball S; Scripps V; Kelleher M; Loader J; Miskin J; Peng YW; Wang WM; Cheung L; Delimont D; Mitrophanous KA; Cosgrove D
PLoS One; 2014; 9(4):e94272. PubMed ID: 24705452
[TBL] [Abstract][Full Text] [Related]
7. Retinal Histopathology in Eyes from a Patient with Stargardt disease caused by Compound Heterozygous ABCA4 Mutations.
Bonilha VL; Rayborn ME; Bell BA; Marino MJ; Fishman GA; Hollyfield JG
Ophthalmic Genet; 2016 Jun; 37(2):150-60. PubMed ID: 25265374
[TBL] [Abstract][Full Text] [Related]
8. Complement modulation in the retinal pigment epithelium rescues photoreceptor degeneration in a mouse model of Stargardt disease.
Lenis TL; Sarfare S; Jiang Z; Lloyd MB; Bok D; Radu RA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3987-3992. PubMed ID: 28348233
[TBL] [Abstract][Full Text] [Related]
9. Development of photoreceptor-specific promoters and their utility to investigate EIAV lentiviral vector mediated gene transfer to photoreceptors.
Nicoud M; Kong J; Iqball S; Kan O; Naylor S; Gouras P; Allikmets R; Binley K
J Gene Med; 2007 Dec; 9(12):1015-23. PubMed ID: 17963276
[TBL] [Abstract][Full Text] [Related]
10. Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina.
Bainbridge JW; Mistry A; Schlichtenbrede FC; Smith A; Broderick C; De Alwis M; Georgiadis A; Taylor PM; Squires M; Sethi C; Charteris D; Thrasher AJ; Sargan D; Ali RR
Gene Ther; 2003 Aug; 10(16):1336-44. PubMed ID: 12883530
[TBL] [Abstract][Full Text] [Related]
11. Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors.
Balaggan KS; Binley K; Esapa M; Iqball S; Askham Z; Kan O; Tschernutter M; Bainbridge JW; Naylor S; Ali RR
J Gene Med; 2006 Mar; 8(3):275-85. PubMed ID: 16299834
[TBL] [Abstract][Full Text] [Related]
12. Localization and functional characterization of the p.Asn965Ser (N965S) ABCA4 variant in mice reveal pathogenic mechanisms underlying Stargardt macular degeneration.
Molday LL; Wahl D; Sarunic MV; Molday RS
Hum Mol Genet; 2018 Jan; 27(2):295-306. PubMed ID: 29145636
[TBL] [Abstract][Full Text] [Related]
13. Full-field ERG as a predictor of the natural course of
Schroeder M; Kjellström U
Mol Vis; 2018; 24():1-16. PubMed ID: 29386879
[TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.
Lamikanra A; Myers KA; Ferris N; Mitrophanous KA; Carroll MW
Gene Ther; 2005 Jun; 12(12):988-98. PubMed ID: 15772687
[TBL] [Abstract][Full Text] [Related]
15. The external limiting membrane in early-onset Stargardt disease.
Lee W; Nõupuu K; Oll M; Duncker T; Burke T; Zernant J; Bearelly S; Tsang SH; Sparrow JR; Allikmets R
Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6139-49. PubMed ID: 25139735
[TBL] [Abstract][Full Text] [Related]
16. Screening of ABCA4 Gene in a Chinese Cohort With Stargardt Disease or Cone-Rod Dystrophy With a Report on 85 Novel Mutations.
Jiang F; Pan Z; Xu K; Tian L; Xie Y; Zhang X; Chen J; Dong B; Li Y
Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):145-52. PubMed ID: 26780318
[TBL] [Abstract][Full Text] [Related]
17. Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease.
Trapani I; Toriello E; de Simone S; Colella P; Iodice C; Polishchuk EV; Sommella A; Colecchi L; Rossi S; Simonelli F; Giunti M; Bacci ML; Polishchuk RS; Auricchio A
Hum Mol Genet; 2015 Dec; 24(23):6811-25. PubMed ID: 26420842
[TBL] [Abstract][Full Text] [Related]
18. Equine infectious anemia viral vector-mediated codelivery of endostatin and angiostatin driven by retinal pigmented epithelium-specific VMD2 promoter inhibits choroidal neovascularization.
Kachi S; Binley K; Yokoi K; Umeda N; Akiyama H; Muramatu D; Iqball S; Kan O; Naylor S; Campochiaro PA
Hum Gene Ther; 2009 Jan; 20(1):31-9. PubMed ID: 20377369
[TBL] [Abstract][Full Text] [Related]
19. Dual AAV Vectors for Stargardt Disease.
Trapani I
Methods Mol Biol; 2018; 1715():153-175. PubMed ID: 29188512
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.
Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ
Mol Vis; 2009; 15():267-75. PubMed ID: 19190735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
